CN113423824A - 用于细菌递送媒介物中的嵌合受体结合蛋白 - Google Patents

用于细菌递送媒介物中的嵌合受体结合蛋白 Download PDF

Info

Publication number
CN113423824A
CN113423824A CN201980090328.8A CN201980090328A CN113423824A CN 113423824 A CN113423824 A CN 113423824A CN 201980090328 A CN201980090328 A CN 201980090328A CN 113423824 A CN113423824 A CN 113423824A
Authority
CN
China
Prior art keywords
virus
rbp
synonym
bacterial
mycobacterium
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201980090328.8A
Other languages
English (en)
Chinese (zh)
Inventor
J·费南德斯-罗德里格斯
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Erig Biotechnology Co ltd
Original Assignee
Erig Biotechnology Co ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erig Biotechnology Co ltd filed Critical Erig Biotechnology Co ltd
Publication of CN113423824A publication Critical patent/CN113423824A/zh
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/71—Expression systems using regulatory sequences derived from the trp-operon
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli
    • C12N15/73—Expression systems using phage (lambda) regulatory sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/22—Ribonucleases [RNase]; Deoxyribonucleases [DNase]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/33—Fusion polypeptide fusions for targeting to specific cell types, e.g. tissue specific targeting, targeting of a bacterial subspecies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10111—Myoviridae
    • C12N2795/10151—Methods of production or purification of viral material
    • C12N2795/10152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2795/00—Bacteriophages
    • C12N2795/00011—Details
    • C12N2795/10011—Details dsDNA Bacteriophages
    • C12N2795/10311—Siphoviridae
    • C12N2795/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2795/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CN201980090328.8A 2018-11-27 2019-11-26 用于细菌递送媒介物中的嵌合受体结合蛋白 Pending CN113423824A (zh)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201862771761P 2018-11-27 2018-11-27
US62/771761 2018-11-27
US201962802777P 2019-02-08 2019-02-08
US62/802777 2019-02-08
PCT/EP2019/082640 WO2020109339A1 (en) 2018-11-27 2019-11-26 Chimeric receptor binding proteins for use in bacterial delivery vehicles

Publications (1)

Publication Number Publication Date
CN113423824A true CN113423824A (zh) 2021-09-21

Family

ID=68731980

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201980090328.8A Pending CN113423824A (zh) 2018-11-27 2019-11-26 用于细菌递送媒介物中的嵌合受体结合蛋白

Country Status (8)

Country Link
US (4) US11661443B2 (https=)
EP (2) EP4374923A3 (https=)
JP (1) JP7764247B2 (https=)
KR (1) KR20210100119A (https=)
CN (1) CN113423824A (https=)
CA (1) CA3120615A1 (https=)
IL (1) IL283089B2 (https=)
WO (1) WO2020109339A1 (https=)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116676277A (zh) * 2023-07-28 2023-09-01 中国海洋大学 一种深渊盐单胞菌溶原性噬菌体及其分离方法和应用
CN116715736A (zh) * 2023-08-07 2023-09-08 山东省农业科学院畜牧兽医研究所 噬菌体尾部纤维蛋白在o2抗原血清型的禽致病性大肠杆菌鉴定中的应用

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4374923A3 (en) 2018-11-27 2024-08-14 Eligo Bioscience Chimeric receptor binding proteins for use in bacterial delivery vehicles
CN110872614A (zh) * 2019-12-05 2020-03-10 深圳市第三人民医院 基于Cas12a/gRNA的快速鉴定分枝杆菌的方法
US11584781B2 (en) 2019-12-30 2023-02-21 Eligo Bioscience Chimeric receptor binding proteins resistant to proteolytic degradation
US20210196828A1 (en) * 2019-12-30 2021-07-01 Eligo Bioscience Bacterial delivery vehicles for in vivo delivery of a dna payload
WO2022144381A1 (en) 2020-12-30 2022-07-07 Eligo Bioscience Microbiome modulation of a host by delivery of dna payloads with minimized spread
JP2024520940A (ja) * 2021-05-12 2024-05-27 エリゴ・バイオサイエンス 産生細菌細胞及び産生方法におけるその使用

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107278227A (zh) * 2014-12-16 2017-10-20 合成基因组股份有限公司 用于体外病毒基因组工程的组合物和方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8445639B2 (en) 2006-05-15 2013-05-21 Avidbiotics Corporation Recombinant bacteriophage and methods for their use
US10660943B2 (en) 2013-02-07 2020-05-26 The Rockefeller University Sequence specific antimicrobials
EP4374923A3 (en) 2018-11-27 2024-08-14 Eligo Bioscience Chimeric receptor binding proteins for use in bacterial delivery vehicles
US11208437B2 (en) 2018-12-21 2021-12-28 Eligo Bioscience Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107278227A (zh) * 2014-12-16 2017-10-20 合成基因组股份有限公司 用于体外病毒基因组工程的组合物和方法

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
HIROKI ANDO等: "Engineering Modular Viral Scaffolds for Targeted Bacterial Population Editing", CELL SYSTEMS, vol. 1, no. 1, pages 190 - 191 *
PATRICK A. DE JONGE等: "Molecular and Evolutionary Determinants of Bacteriophage Host Range", TRENDS IN MICROBIOLOGY, vol. 29, no. 1, pages 57 *

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN116676277A (zh) * 2023-07-28 2023-09-01 中国海洋大学 一种深渊盐单胞菌溶原性噬菌体及其分离方法和应用
CN116676277B (zh) * 2023-07-28 2023-11-03 中国海洋大学 一种深渊盐单胞菌溶原性噬菌体及其分离方法和应用
CN116715736A (zh) * 2023-08-07 2023-09-08 山东省农业科学院畜牧兽医研究所 噬菌体尾部纤维蛋白在o2抗原血清型的禽致病性大肠杆菌鉴定中的应用
CN116715736B (zh) * 2023-08-07 2023-11-14 山东省农业科学院畜牧兽医研究所 噬菌体尾部纤维蛋白在o2抗原血清型的禽致病性大肠杆菌鉴定中的应用

Also Published As

Publication number Publication date
EP4374923A3 (en) 2024-08-14
US20220112247A1 (en) 2022-04-14
US20200277337A1 (en) 2020-09-03
IL283089B1 (en) 2025-07-01
EP4374923A2 (en) 2024-05-29
KR20210100119A (ko) 2021-08-13
US11661443B2 (en) 2023-05-30
US11512116B2 (en) 2022-11-29
CA3120615A1 (en) 2020-06-04
JP7764247B2 (ja) 2025-11-05
US20230279058A1 (en) 2023-09-07
IL283089A (en) 2021-06-30
US11236133B2 (en) 2022-02-01
US20200190147A1 (en) 2020-06-18
IL283089B2 (en) 2025-11-01
EP3887511A1 (en) 2021-10-06
JP2022513141A (ja) 2022-02-07
WO2020109339A1 (en) 2020-06-04

Similar Documents

Publication Publication Date Title
US11512116B2 (en) Chimeric receptor binding proteins for use in bacterial delivery vehicles
KR102563835B1 (ko) 미생물군에서의 전달을 위해 최적화된 벡터
CN113498435A (zh) 用于细菌递送媒介物中的分支受体结合多亚基蛋白复合物
US11208437B2 (en) Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles
US20210380953A1 (en) Bacterial delivery vehicle, process of production and uses thereof
US11970716B2 (en) Transcriptional control in prokaryotic cells using DNA-binding repressors
CA3164131A1 (en) Bacterial delivery vehicles for in vivo delivery of a dna payload
US20210196828A1 (en) Bacterial delivery vehicles for in vivo delivery of a dna payload
US20220064223A1 (en) Branched receptor binding multi-subunit protein complexes for use in bacterial delivery vehicles
JP2024501871A (ja) タンパク質分解に耐性のキメラ受容体結合タンパク質
HK40111917A (en) Chimeric receptor binding proteins for use in bacterial delivery vehicles
CN116940676A (zh) 抵抗蛋白水解降解的嵌合受体结合蛋白

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination